BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33742084)

  • 1. Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes.
    Gardner KP; Aldakkak M; Tang CM; Tsai S; Adams DL
    NPJ Precis Oncol; 2021 Mar; 5(1):25. PubMed ID: 33742084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.
    Gardner KP; Tsai S; Aldakkak M; Gironda S; Adams DL
    PLoS One; 2022; 17(3):e0264763. PubMed ID: 35259193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
    Mu Z; Wang C; Ye Z; Rossi G; Sun C; Li L; Zhu Z; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2017 Oct; 165(3):733-741. PubMed ID: 28687903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy.
    Gironda DJ; Adams DL; He J; Xu T; Gao H; Qiao Y; Komaki R; Reuben JM; Liao Z; Blum-Murphy M; Hofstetter WL; Tang CM; Lin SH
    J Transl Med; 2020 Nov; 18(1):413. PubMed ID: 33148307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Vaselaar E; Ageton C; Gaster K; Espaillat LR; Starks D; Dey N
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time.
    Ali A; Adams DL; Kasabwala DM; Tang CM; Ho TH
    Sci Rep; 2023 Jun; 13(1):10544. PubMed ID: 37386095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma.
    Nitschke C; Markmann B; Konczalla L; Kropidlowski J; Pereira-Veiga T; Scognamiglio P; Schönrock M; Sinn M; Tölle M; Izbicki J; Pantel K; Uzunoglu FG; Wikman H
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
    Adams DL; Adams DK; Alpaugh RK; Cristofanilli M; Martin SS; Chumsri S; Tang CM; Marks JR
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1037-42. PubMed ID: 27197300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings.
    Gironda DJ; Bergan RC; Alpaugh RK; Danila DC; Chuang TL; Hurtado BY; Ho T; Adams DL
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer.
    Kasabwala DM; Bergan RC; Gardner KP; Lapidus R; Tsai S; Aldakkak M; Adams DL
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.
    Cheng H; Luo G; Lu Y; Jin K; Guo M; Xu J; Long J; Liu L; Yu X; Liu C
    Pancreatology; 2016; 16(6):1080-1084. PubMed ID: 27665172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients.
    Rangel-Pozzo A; Wechsler J; Groult J; Da Meda L; Lebbe C; Mai S
    Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer.
    Wu C; Wu Z; Tian B
    BMC Surg; 2020 Sep; 20(1):207. PubMed ID: 32943033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis.
    Zhu P; Stanton ML; Castle EP; Joseph RW; Adams DL; Li S; Amstutz P; Tang CM; Ho TH
    J Transl Med; 2016 Jul; 14(1):198. PubMed ID: 27369977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
    Kuvendjiska J; Pitman MB; Martini V; Braun C; Grebe K; Timme S; Fichtner-Feigl S; Glatz T; Schmoor C; Guenzle J; Hoeppner J; Kulemann B
    Anticancer Res; 2020 Oct; 40(10):5679-5685. PubMed ID: 32988893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
    Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
    Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study.
    Caputo D; Cartillone M; Cascone C; Pozzi D; Digiacomo L; Palchetti S; Caracciolo G; Coppola R
    Pancreatology; 2018 Sep; 18(6):661-665. PubMed ID: 29914752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.